New York, USA, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Coagulation Analyzers Global Market is Projected to Rise at a CAGR of ~5% by 2028 | DelveInsight
The global coagulation analyzers market is anticipated to grow significantly owing to the factors such as the increasing prevalence of various cardiovascular diseases and bleeding disorders such as coronary heart disease, peripheral arterial disease, hemophilia, von Willebrand disease, and others, as well as an increase in awareness programs and initiatives, along with the increased product development activities such as product launches and regulatory approvals.
DelveInsight’s Coagulation Analyzers Market Insights report provides the current and forecast market analysis, individual leading coagulation analyzers companies’ market shares, challenges, coagulation analyzers market drivers, barriers, trends, and key market coagulation analyzers companies in the market.
Key Takeaways from the Coagulation Analyzers Market Report
- As per DelveInsight estimates, North America is anticipated to dominate the global coagulation analyzers market during the forecast period.
- Notable coagulation analyzers companies such as Abbott, Siemens Healthcare GmbH, Sysmex Corporation, Thermo Fisher Scientific Corporation, F. Hoffmann-La Roche Ltd., HORIBA Medical, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Maccura Biotechnology Co., Ltd., Bio-Group Medical System srl, Genrui Biotech Co., Ltd., Tokuyama Corporation, Stago, Beijing Succeeder Technology Inc., Helena Laboratories Corporation, BIOLABO S.A.S., Meril Life Sciences Pvt. Ltd., SCLAVO Diagnostics International S.p.A, Erba Mannheim, ACON Laboratories, Inc., Haemonetics Corporation, and several others, are currently operating in the coagulation analyzers market.
- In March 2023, Sysmex and Siemens Healthineers established a global agreement to supply hemostasis instruments and reagents as OEMs, under which each company will supply the other with their products in the diagnostic field of hemostasis on an OEM basis.
- In December 2022, Durham-based medical device developer Hemosonics received US FDA approval for its Quantra Hemostasis System with QStat Cartridge to assist doctors in evaluating whole blood samples to determine how well the blood is clotting.
- In February 2022, Horiba UK, a subsidiary of Horiba Medical, launched the new high throughput hemostasis analyzer known as the new Yumizen G1550 automated hemostasis analyzer and Microsemi CRP LC-767G POC hematology analyzer in the UK.
- In October 2021, Trivitron Healthcare, a leading medical devices company announced the launch of a new line of Coagulation Analyzer products manufactured by Diagon Ltd
- In July 2021, Sysmex Europe launched two new automated blood coagulation analyzers, CN-3500 and CN-6500, in specific countries in the EMEA region. They are targeted at medium- and large-scale hospitals and commercial labs, as well as other facilities.
To read more about the latest highlights related to the coagulation analyzers market, get a snapshot of the key highlights entailed in the Global Coagulation Analyzers Market Report
Coagulation Analyzers Overview
Coagulation analyzers are sophisticated medical devices designed to assess the clotting properties of blood. They play a critical role in diagnosing and monitoring various medical conditions related to blood coagulation and clotting disorders. These analyzers are essential tools in clinical laboratories and healthcare settings, providing valuable information to healthcare professionals for accurate and timely patient care. Coagulation analyzers work based on the principle of detecting changes in the clotting process of blood samples. The most common method used is called the clotting time or clotting-based method. In this approach, the analyzer measures the time taken for blood to form a clot after the addition of specific reagents. The clotting time is influenced by various clotting factors and components present in the blood, such as fibrinogen, platelets, and coagulation factors.
Coagulation Analyzers Market Insights
North America accounted for the highest share of the coagulation analyzers market in 2022, with a share of 38.69%. Factors such as the rising frequency of blood disorders such as hemophilia, von Willebrand disease, sickle cell disease, and others will have an impact on the region’s coagulation analyzer market. Furthermore, rising healthcare expenditures and rising research and development activities in the region as a result of the rapid launch and approval of new coagulation analyzers are boosting the coagulation analyzers market expansion in North America.
In addition to the factors described above, strategic activities such as product launches and approvals, mergers, acquisitions, collaborations, investments, and others contribute to promoting regional product demand. For example, Durham-based medical device firm Hemosonics gained US FDA approval in December 2022 for its Quantra Hemostasis System with QStat Cartridge to assist doctors in reviewing whole blood samples to determine how effectively the blood clots. As a result, such strategic initiatives help to improve demand for coagulation analyzers, propelling the North American coagulation analyzers market forward during the forecast period.
To know more about why North America is leading the market growth in the coagulation analyzers market, get a snapshot of the Coagulation Analyzers Market Outlook
Coagulation Analyzers Market Dynamics
The coagulation analyzers market is expanding due to a variety of factors, one of which is the rising prevalence of cardiovascular disorders. The growing number of cardiovascular procedures that use coagulation analyzers to assess potential risk for hypercoagulability or thrombophilia before, during, and after the procedure will also drive up demand for coagulation analyzers. Another key factor driving the growth of the coagulation analyzers market is the increasing number of people suffering from bleeding diseases such as hemophilia, von Willebrand disease, and others.
Chronic blood diseases have a profound influence on patients’ and their families’ health and quality of life. They are capable of causing discomfort, loss of normal functioning, sadness, anxiety, financial load, long-term hospitalization, and even death. Coagulant analyzers detect clot deficits, measure coagulation pathway speed, and thrombin levels, and are also used to evaluate drug effects on whole blood. As a result, early diagnosis of heart problems and other blood disorders using coagulation analyzers is critical and will drive the global coagulation analyzers market during the forecast period.
However, a shortage of qualified specialists, which leads to errors, an increasing number of product recalls, and other factors may limit the coagulation analyzers market expansion in the coming years.
Get a sneak peek at the coagulation analyzers market dynamics @ Coagulation Analyzers Market Dynamics Analysis
| Report Metrics | Details |
| Coverage | Global |
| Study Period | 2020–2028 |
| Coagulation Analyzers Market CAGR | ~5% |
| Coagulation Analyzers Market Size by 2028 | USD 4.50 Billion |
| Key Coagulation Analyzers Companies | Abbott, Siemens Healthcare GmbH, Sysmex Corporation, Thermo Fisher Scientific Corporation, F. Hoffmann-La Roche Ltd., HORIBA Medical, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Maccura Biotechnology Co., Ltd., Bio-Group Medical System srl, Genrui Biotech Co., Ltd., Tokuyama Corporation, Stago, Beijing Succeeder Technology Inc., Helena Laboratories Corporation, BIOLABO S.A.S., Meril Life Sciences Pvt. Ltd., SCLAVO Diagnostics International S.p.A, Erba Mannheim, ACON Laboratories, Inc., Haemonetics Corporation, among others |
Coagulation Analyzers Market Assessment
- Coagulation Analyzers Market Segmentation
- Coagulation Analyzers Market Segmentation By Product Type: Instruments (Automated Analyzers, Semi-Automated Analyzers, And Manual Analyzers) and Reagents and Consumables
- Coagulation Analyzers Market Segmentation By Test Type: Fibrinogen Testing, Activated Clotting Time Testing, D-Dimer Testing, Prothrombin Time, and Others
- Coagulation Analyzers Market Segmentation By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology, and Others
- Coagulation Analyzers Market Segmentation By End User: Hospitals, Diagnostic Centers, and Others
- Coagulation Analyzers Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
Which MedTech key players in the coagulation analyzers market are set to emerge as the trendsetter explore @ Coagulation Analyzers Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Coagulation Analyzers Market |
| 7 | Coagulation Analyzers Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Coagulation Analyzers Market Company and Product Profiles |
| 10 | Project Approach |
| 11 | About DelveInsight |
Interested in knowing the coagulation analyzers market by 2028? Click to get a snapshot of the Coagulation Analyzers Market Trends
Related Reports
Hemophilia Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Hemophilia companies, including Intellia tx, Amarna therapeutics, Expressi Ontherapeutics, GC Pharma, Chameleon Biosciences, Pfizer, UBI Pharma, GeneVentiv, Chia Tai Tianqing Pharmaceutical Group, Bayer, ASC Therapeutics, Catalyst Biosciences, Staidson Beijing BioPharmaceuticals, Spark Therapeutics, CSL Behring, Sanofi, Novo Nordisk, Centessa Pharmaceuticals, OPKO Health, among others.
Von Willebrand Disease Pipeline
Von Willebrand Disease Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key Von Willebrand disease companies, including Band Therapeutics, TagCyx Biotechnologies, China Biologic Products, Thrombotargets Corporation, Sanofi, among others.
Von Willebrand Disease Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key Von Willebrand disease companies, including Band Therapeutics, TagCyx Biotechnologies, China Biologic Products, Thrombotargets Corporation, Sanofi, among others.
Hemophilia Epidemiology Forecast
Hemophilia Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted hemophilia epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Hemophilia A Market Insights, Epidemiology, and Market Forecast – 2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key hemophilia A companies, including Centessa Pharmaceuticals, Alnylam Pharmaceuticals, ASC Therapeutics, Spark Therapeutics, among others.
Hemophilia B Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key hemophilia B companies, including ASC Therapeutics, Spark Therapeutics, Roche, Pfizer, among others.
Other Trending Reports
Ophthalmic Imaging Equipment Market | Pertussis Market | Recurrent Blood Clots Market | Respiratory Syncytial Virus Market | Systemic Juvenile Idiopathic Arthritis Market | Urethral Stricture Treatment Devices Market | Uterine Serous Carcinoma Market | Zollinger-Ellison Syndrome Market | Acanthamoeba Keratitis Market | Acquired Hemophilia A Pipeline | Acute Pain Market | Age-Related Hearing Loss Medical Device Market | Angio Suites Market | Balloon Catheters Market | Bartonellosis Market | Candidemia Market | Chronic Hand Eczema Market | Chronic Refractory Gout Market | Encephalomyelitis Market | Eosinophilic Gastroenteritis Market | Follicular Lymphoma Market | Head And Neck Squamous Cell Carcinoma Market | Heart Sounds Sensors Market | Heavy Metal Poisoning Market | Hyperinsulinemic Hypoglycemia Market | Hypoplastic Left Heart Syndrome Hlhs Market | Infectious Arthritis/Septic Arthritis Market | Microvascular Angina Market | Mucinoses Market | Necrotizing Enterocolitis Market | Neurofibromatosis 2 Market | Osteochondrodysplasia Market | Plasmacytoma Market | Post-Cardiac Arrest Syndrome Pcas Market | Progressive Familial Intrahepatic Cholestasis Market | Progressive Supranuclear Palsy Market | Pyruvate Kinase Deficiency Market | Recurrent Pericarditis Market | Relapsing Refractory Multiple Myeloma Market | Renal Fanconi Syndrome Market | Wiskott-Aldrich Syndrome Market | Advanced Cancer Pain Management Market | Agoraphobia Market | Alagille Syndrome Market | Atypical Hemolytic Uremic Syndrome Ahus Market | Clinically Isolated Syndrome CIS Market | Conductive Hearing Loss Market | Condyloma Market | Familial Lipoprotein Lipase Deficiency Market | Fucosidosis Market | Glaucoma Drainage Devices Market | H3N2 Infection Market | Hepatitis D Market | Hypopituitarism Market | Hypothalamic Obesity Market | Major Depressive Disorder Market | Muscle Spasticity Market | Musculoskeletal Pain Market Insights | Neurofibromatosis Type 2 Market | Neuronal Ceroid-Lipofuscinoses Market | Paranasal Sinus Cancer Market | Portal Hypertension Market | Propionic Acidemia Market | Systemic Inflammatory Response Syndrome Market Insights | Walking Impairment In Multiple Sclerosis Market | Wet-Age-Related Macular Degeneration Market
Related Healthcare Services
Healthcare Competitive Intelligence Services
Healthcare Asset Prioritization Services
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
